Results 101 to 110 of about 1,657,556 (272)
Fluorescent probes allow dynamic visualization of phosphoinositides in living cells (left), whereas mass spectrometry provides high‐sensitivity, isomer‐resolved quantitation (right). Their synergistic use captures complementary aspects of lipid signaling. This review illustrates how these approaches reveal the spatiotemporal regulation and quantitative
Hiroaki Kajiho +3 more
wiley +1 more source
Strengthening capacity for monitoring and evaluation through short course training in Kenya
Background: Weak monitoring and evaluation (M&E) systems and limited supply of M&E human resources in Africa signal the need to strengthen M&E capacity.
Hesborn Wao +4 more
doaj +1 more source
Creation of public use files: lessons learned from the comparative effectiveness research public use files data pilot project [PDF]
In this paper we describe lessons learned from the creation of Basic Stand Alone (BSA) Public Use Files (PUFs) for the Comparative Effectiveness Research Public Use Files Data Pilot Project (CER-PUF).
Erdem, Erkan, Prada, Sergio I
core
A new paradigm evaluating cost per cure of HCV infection in the UK [PDF]
Background: New interferon (IFN)-free treatments for hepatitis C are more effective, safer but more expensive than current IFN-based therapies. Comparative data of these, versus current first generation protease inhibitors (PI) with regard to costs and ...
Aline Gauthier +7 more
core +2 more sources
By dawn or dusk—how circadian timing rewrites bacterial infection outcomes
The circadian clock shapes immune function, yet its influence on infection outcomes is only beginning to be understood. This review highlights how circadian timing alters host responses to the bacterial pathogens Salmonella enterica, Listeria monocytogenes, and Streptococcus pneumoniae revealing that the effectiveness of immune defense depends not only
Devons Mo +2 more
wiley +1 more source
Introduction Trauma and injury are significant contributors to the global burden of disease, with 5 million deaths and 250 million disability-adjusted life years lost in 2015.
Raul Coimbra +3 more
doaj +1 more source
Effect Identification in Comparative Effectiveness Research
The widespread adoption of electronic medical records means there are now vast data resources available for comparative effectiveness research (CER). In concert with conventional randomized controlled trials, CER holds great promise for advancing our understanding of how different therapeutic treatments yield ...
openaire +2 more sources
Methods in Comparative Effectiveness Research [PDF]
Comparative effectiveness research (CER) seeks to assist consumers, clinicians, purchasers, and policy makers to make informed decisions to improve health care at both the individual and population levels. CER includes evidence generation and evidence synthesis.
openaire +2 more sources
Choosing Important Health Outcomes for Comparative Effectiveness Research: An Updated Review and Identification of Gaps [PDF]
BackgroundThe COMET (Core Outcome Measures in Effectiveness Trials) Initiative promotes the development and application of core outcome sets (COS), including relevant studies in an online database.
Clarke, Mike +4 more
core +2 more sources
Phosphatidylinositol 4‐kinase as a target of pathogens—friend or foe?
This graphical summary illustrates the roles of phosphatidylinositol 4‐kinases (PI4Ks). PI4Ks regulate key cellular processes and can be hijacked by pathogens, such as viruses, bacteria and parasites, to support their intracellular replication. Their dual role as essential host enzymes and pathogen cofactors makes them promising drug targets.
Ana C. Mendes +3 more
wiley +1 more source

